Figure 4.
Figure 4. Acute MCMV infection impairs generation of Gr1HI-MDSCs. (A) Kinetics of circulating CD11b+Gr1HI MDSCs in ECDI-SP–treated, either uninfected or Δm157-infected (on day 0), transplant recipients. Total live CD11b+Gr1HI cells were enumerated by FACS in 50 µL of blood drawn on the indicated days. (B) Quantitative analysis of total CD11b+Gr1HI cells in 50 µL of blood collected on day 10 posttransplantation from recipients of the indicated groups. Data shown in panels A and B were from 2 to 3 independent experiments with a total of 4 to 6 mice in each group. *P < .05. (C) Representative histograms of expression of C5aR and FcγRII/III on circulating Gr1HI-MDSCs on day 10 posttransplantation from naïve or transplant recipients with or without day 0 Δm157 infection. (D) Mean fluorescence intensities (MFI) of C5aR and FcγRII/III of groups shown in panel C. Data presented in panels C and D were obtained from 2 independent experiments with a total of 4 mice in each group. (E) In vitro suppression assay using Gr1HI-MDSCs sorted from the spleen of the indicated groups 10 days posttransplantation. Sorted Gr1HI-MDSCs were cocultured with CFSE-labeled syngeneic CD8 T cells stimulated with anti-CD3/CD28 coated beads (at a ratio of 1:1:1). Proliferation of CD8 T cells was measured by CFSE dilution by FACS. (F) Quantification of CD8 T-cell proliferation in the presence of Gr1HI-MDSCs sorted from the indicated groups shown in panel E. Data shown in panels E and F were obtained from 2 independent experiments with a total of 4 mice in each group. Data were presented as mean ± SD. *P < .05. (G) Representative FACS plot depicting the purity of sorted Gr1HI cells pooled from the BM and the spleen of naïve B6 mice used for adoptive transfers. (H) Schematic treatment plan and percent graft survival with adoptive transfer of sorted Gr1HI cells. Two cohorts of ECDI-SP–treated transplant recipients were infected with Δm157 on day 0. The first cohort additionally received ∼30 × 106 sorted Gr1HI cells on the indicated days, while the other cohort did not receive any cells (N = 3-4, compiled from 2 independent experiments). *P < .05 (log-rank test).

Acute MCMV infection impairs generation of Gr1HI-MDSCs. (A) Kinetics of circulating CD11b+Gr1HI MDSCs in ECDI-SP–treated, either uninfected or Δm157-infected (on day 0), transplant recipients. Total live CD11b+Gr1HI cells were enumerated by FACS in 50 µL of blood drawn on the indicated days. (B) Quantitative analysis of total CD11b+Gr1HI cells in 50 µL of blood collected on day 10 posttransplantation from recipients of the indicated groups. Data shown in panels A and B were from 2 to 3 independent experiments with a total of 4 to 6 mice in each group. *P < .05. (C) Representative histograms of expression of C5aR and FcγRII/III on circulating Gr1HI-MDSCs on day 10 posttransplantation from naïve or transplant recipients with or without day 0 Δm157 infection. (D) Mean fluorescence intensities (MFI) of C5aR and FcγRII/III of groups shown in panel C. Data presented in panels C and D were obtained from 2 independent experiments with a total of 4 mice in each group. (E) In vitro suppression assay using Gr1HI-MDSCs sorted from the spleen of the indicated groups 10 days posttransplantation. Sorted Gr1HI-MDSCs were cocultured with CFSE-labeled syngeneic CD8 T cells stimulated with anti-CD3/CD28 coated beads (at a ratio of 1:1:1). Proliferation of CD8 T cells was measured by CFSE dilution by FACS. (F) Quantification of CD8 T-cell proliferation in the presence of Gr1HI-MDSCs sorted from the indicated groups shown in panel E. Data shown in panels E and F were obtained from 2 independent experiments with a total of 4 mice in each group. Data were presented as mean ± SD. *P < .05. (G) Representative FACS plot depicting the purity of sorted Gr1HI cells pooled from the BM and the spleen of naïve B6 mice used for adoptive transfers. (H) Schematic treatment plan and percent graft survival with adoptive transfer of sorted Gr1HI cells. Two cohorts of ECDI-SP–treated transplant recipients were infected with Δm157 on day 0. The first cohort additionally received ∼30 × 106 sorted Gr1HI cells on the indicated days, while the other cohort did not receive any cells (N = 3-4, compiled from 2 independent experiments). *P < .05 (log-rank test).

Close Modal

or Create an Account

Close Modal
Close Modal